Request for Covid-19 Impact Assessment of this Report
The United States Eye Drops for Glaucoma market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Eye Drops for Glaucoma market, reaching US$ million by the year 2028. As for the Europe Eye Drops for Glaucoma landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Eye Drops for Glaucoma players cover Thea Pharmaceuticals Ltd, FDC International Ltd, Martindale Pharma, and Zentiva, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Eye Drops for Glaucoma market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Bimatoprost
Latanoprost
Tafluprost
Travoprost
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Ophthalmic Clinic
Pharmacy
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Thea Pharmaceuticals Ltd
FDC International Ltd
Martindale Pharma
Zentiva
Upjohn UK Limited
Beacon Pharmaceuticals
Novartis Pharmaceuticals UK Ltd
Mylan
Accord Healthcare Limited
Sandoz Limited
Thornton & Ross Ltd
Aspire Pharma Ltd
AbbVie Ltd
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Eye Drops for Glaucoma Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Eye Drops for Glaucoma by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Eye Drops for Glaucoma by Country/Region, 2017, 2022 & 2028
2.2 Eye Drops for Glaucoma Segment by Type
2.2.1 Bimatoprost
2.2.2 Latanoprost
2.2.3 Tafluprost
2.2.4 Travoprost
2.3 Eye Drops for Glaucoma Sales by Type
2.3.1 Global Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)
2.3.2 Global Eye Drops for Glaucoma Revenue and Market Share by Type (2017-2022)
2.3.3 Global Eye Drops for Glaucoma Sale Price by Type (2017-2022)
2.4 Eye Drops for Glaucoma Segment by Application
2.4.1 Hospital
2.4.2 Ophthalmic Clinic
2.4.3 Pharmacy
2.4.4 Others
2.5 Eye Drops for Glaucoma Sales by Application
2.5.1 Global Eye Drops for Glaucoma Sale Market Share by Application (2017-2022)
2.5.2 Global Eye Drops for Glaucoma Revenue and Market Share by Application (2017-2022)
2.5.3 Global Eye Drops for Glaucoma Sale Price by Application (2017-2022)
3 Global Eye Drops for Glaucoma by Company
3.1 Global Eye Drops for Glaucoma Breakdown Data by Company
3.1.1 Global Eye Drops for Glaucoma Annual Sales by Company (2020-2022)
3.1.2 Global Eye Drops for Glaucoma Sales Market Share by Company (2020-2022)
3.2 Global Eye Drops for Glaucoma Annual Revenue by Company (2020-2022)
3.2.1 Global Eye Drops for Glaucoma Revenue by Company (2020-2022)
3.2.2 Global Eye Drops for Glaucoma Revenue Market Share by Company (2020-2022)
3.3 Global Eye Drops for Glaucoma Sale Price by Company
3.4 Key Manufacturers Eye Drops for Glaucoma Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Eye Drops for Glaucoma Product Location Distribution
3.4.2 Players Eye Drops for Glaucoma Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Eye Drops for Glaucoma by Geographic Region
4.1 World Historic Eye Drops for Glaucoma Market Size by Geographic Region (2017-2022)
4.1.1 Global Eye Drops for Glaucoma Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Eye Drops for Glaucoma Annual Revenue by Geographic Region
4.2 World Historic Eye Drops for Glaucoma Market Size by Country/Region (2017-2022)
4.2.1 Global Eye Drops for Glaucoma Annual Sales by Country/Region (2017-2022)
4.2.2 Global Eye Drops for Glaucoma Annual Revenue by Country/Region
4.3 Americas Eye Drops for Glaucoma Sales Growth
4.4 APAC Eye Drops for Glaucoma Sales Growth
4.5 Europe Eye Drops for Glaucoma Sales Growth
4.6 Middle East & Africa Eye Drops for Glaucoma Sales Growth
5 Americas
5.1 Americas Eye Drops for Glaucoma Sales by Country
5.1.1 Americas Eye Drops for Glaucoma Sales by Country (2017-2022)
5.1.2 Americas Eye Drops for Glaucoma Revenue by Country (2017-2022)
5.2 Americas Eye Drops for Glaucoma Sales by Type
5.3 Americas Eye Drops for Glaucoma Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Eye Drops for Glaucoma Sales by Region
6.1.1 APAC Eye Drops for Glaucoma Sales by Region (2017-2022)
6.1.2 APAC Eye Drops for Glaucoma Revenue by Region (2017-2022)
6.2 APAC Eye Drops for Glaucoma Sales by Type
6.3 APAC Eye Drops for Glaucoma Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Eye Drops for Glaucoma by Country
7.1.1 Europe Eye Drops for Glaucoma Sales by Country (2017-2022)
7.1.2 Europe Eye Drops for Glaucoma Revenue by Country (2017-2022)
7.2 Europe Eye Drops for Glaucoma Sales by Type
7.3 Europe Eye Drops for Glaucoma Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Eye Drops for Glaucoma by Country
8.1.1 Middle East & Africa Eye Drops for Glaucoma Sales by Country (2017-2022)
8.1.2 Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2017-2022)
8.2 Middle East & Africa Eye Drops for Glaucoma Sales by Type
8.3 Middle East & Africa Eye Drops for Glaucoma Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Eye Drops for Glaucoma
10.3 Manufacturing Process Analysis of Eye Drops for Glaucoma
10.4 Industry Chain Structure of Eye Drops for Glaucoma
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Eye Drops for Glaucoma Distributors
11.3 Eye Drops for Glaucoma Customer
12 World Forecast Review for Eye Drops for Glaucoma by Geographic Region
12.1 Global Eye Drops for Glaucoma Market Size Forecast by Region
12.1.1 Global Eye Drops for Glaucoma Forecast by Region (2023-2028)
12.1.2 Global Eye Drops for Glaucoma Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Eye Drops for Glaucoma Forecast by Type
12.7 Global Eye Drops for Glaucoma Forecast by Application
13 Key Players Analysis
13.1 Thea Pharmaceuticals Ltd
13.1.1 Thea Pharmaceuticals Ltd Company Information
13.1.2 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product Offered
13.1.3 Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Thea Pharmaceuticals Ltd Main Business Overview
13.1.5 Thea Pharmaceuticals Ltd Latest Developments
13.2 FDC International Ltd
13.2.1 FDC International Ltd Company Information
13.2.2 FDC International Ltd Eye Drops for Glaucoma Product Offered
13.2.3 FDC International Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 FDC International Ltd Main Business Overview
13.2.5 FDC International Ltd Latest Developments
13.3 Martindale Pharma
13.3.1 Martindale Pharma Company Information
13.3.2 Martindale Pharma Eye Drops for Glaucoma Product Offered
13.3.3 Martindale Pharma Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Martindale Pharma Main Business Overview
13.3.5 Martindale Pharma Latest Developments
13.4 Zentiva
13.4.1 Zentiva Company Information
13.4.2 Zentiva Eye Drops for Glaucoma Product Offered
13.4.3 Zentiva Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Zentiva Main Business Overview
13.4.5 Zentiva Latest Developments
13.5 Upjohn UK Limited
13.5.1 Upjohn UK Limited Company Information
13.5.2 Upjohn UK Limited Eye Drops for Glaucoma Product Offered
13.5.3 Upjohn UK Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Upjohn UK Limited Main Business Overview
13.5.5 Upjohn UK Limited Latest Developments
13.6 Beacon Pharmaceuticals
13.6.1 Beacon Pharmaceuticals Company Information
13.6.2 Beacon Pharmaceuticals Eye Drops for Glaucoma Product Offered
13.6.3 Beacon Pharmaceuticals Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Beacon Pharmaceuticals Main Business Overview
13.6.5 Beacon Pharmaceuticals Latest Developments
13.7 Novartis Pharmaceuticals UK Ltd
13.7.1 Novartis Pharmaceuticals UK Ltd Company Information
13.7.2 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product Offered
13.7.3 Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Novartis Pharmaceuticals UK Ltd Main Business Overview
13.7.5 Novartis Pharmaceuticals UK Ltd Latest Developments
13.8 Mylan
13.8.1 Mylan Company Information
13.8.2 Mylan Eye Drops for Glaucoma Product Offered
13.8.3 Mylan Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Mylan Main Business Overview
13.8.5 Mylan Latest Developments
13.9 Accord Healthcare Limited
13.9.1 Accord Healthcare Limited Company Information
13.9.2 Accord Healthcare Limited Eye Drops for Glaucoma Product Offered
13.9.3 Accord Healthcare Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Accord Healthcare Limited Main Business Overview
13.9.5 Accord Healthcare Limited Latest Developments
13.10 Sandoz Limited
13.10.1 Sandoz Limited Company Information
13.10.2 Sandoz Limited Eye Drops for Glaucoma Product Offered
13.10.3 Sandoz Limited Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Sandoz Limited Main Business Overview
13.10.5 Sandoz Limited Latest Developments
13.11 Thornton & Ross Ltd
13.11.1 Thornton & Ross Ltd Company Information
13.11.2 Thornton & Ross Ltd Eye Drops for Glaucoma Product Offered
13.11.3 Thornton & Ross Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Thornton & Ross Ltd Main Business Overview
13.11.5 Thornton & Ross Ltd Latest Developments
13.12 Aspire Pharma Ltd
13.12.1 Aspire Pharma Ltd Company Information
13.12.2 Aspire Pharma Ltd Eye Drops for Glaucoma Product Offered
13.12.3 Aspire Pharma Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Aspire Pharma Ltd Main Business Overview
13.12.5 Aspire Pharma Ltd Latest Developments
13.13 AbbVie Ltd
13.13.1 AbbVie Ltd Company Information
13.13.2 AbbVie Ltd Eye Drops for Glaucoma Product Offered
13.13.3 AbbVie Ltd Eye Drops for Glaucoma Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 AbbVie Ltd Main Business Overview
13.13.5 AbbVie Ltd Latest Developments
14 Research Findings and Conclusion
Table 1. Eye Drops for Glaucoma Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Eye Drops for Glaucoma Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Bimatoprost
Table 4. Major Players of Latanoprost
Table 5. Major Players of Tafluprost
Table 6. Major Players of Travoprost
Table 7. Global Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 8. Global Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)
Table 9. Global Eye Drops for Glaucoma Revenue by Type (2017-2022) & ($ million)
Table 10. Global Eye Drops for Glaucoma Revenue Market Share by Type (2017-2022)
Table 11. Global Eye Drops for Glaucoma Sale Price by Type (2017-2022) & (US$/Unit)
Table 12. Global Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 13. Global Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)
Table 14. Global Eye Drops for Glaucoma Revenue by Application (2017-2022)
Table 15. Global Eye Drops for Glaucoma Revenue Market Share by Application (2017-2022)
Table 16. Global Eye Drops for Glaucoma Sale Price by Application (2017-2022) & (US$/Unit)
Table 17. Global Eye Drops for Glaucoma Sales by Company (2020-2022) & (K Units)
Table 18. Global Eye Drops for Glaucoma Sales Market Share by Company (2020-2022)
Table 19. Global Eye Drops for Glaucoma Revenue by Company (2020-2022) ($ Millions)
Table 20. Global Eye Drops for Glaucoma Revenue Market Share by Company (2020-2022)
Table 21. Global Eye Drops for Glaucoma Sale Price by Company (2020-2022) & (US$/Unit)
Table 22. Key Manufacturers Eye Drops for Glaucoma Producing Area Distribution and Sales Area
Table 23. Players Eye Drops for Glaucoma Products Offered
Table 24. Eye Drops for Glaucoma Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 25. New Products and Potential Entrants
Table 26. Mergers & Acquisitions, Expansion
Table 27. Global Eye Drops for Glaucoma Sales by Geographic Region (2017-2022) & (K Units)
Table 28. Global Eye Drops for Glaucoma Sales Market Share Geographic Region (2017-2022)
Table 29. Global Eye Drops for Glaucoma Revenue by Geographic Region (2017-2022) & ($ millions)
Table 30. Global Eye Drops for Glaucoma Revenue Market Share by Geographic Region (2017-2022)
Table 31. Global Eye Drops for Glaucoma Sales by Country/Region (2017-2022) & (K Units)
Table 32. Global Eye Drops for Glaucoma Sales Market Share by Country/Region (2017-2022)
Table 33. Global Eye Drops for Glaucoma Revenue by Country/Region (2017-2022) & ($ millions)
Table 34. Global Eye Drops for Glaucoma Revenue Market Share by Country/Region (2017-2022)
Table 35. Americas Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)
Table 36. Americas Eye Drops for Glaucoma Sales Market Share by Country (2017-2022)
Table 37. Americas Eye Drops for Glaucoma Revenue by Country (2017-2022) & ($ Millions)
Table 38. Americas Eye Drops for Glaucoma Revenue Market Share by Country (2017-2022)
Table 39. Americas Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 40. Americas Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)
Table 41. Americas Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 42. Americas Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)
Table 43. APAC Eye Drops for Glaucoma Sales by Region (2017-2022) & (K Units)
Table 44. APAC Eye Drops for Glaucoma Sales Market Share by Region (2017-2022)
Table 45. APAC Eye Drops for Glaucoma Revenue by Region (2017-2022) & ($ Millions)
Table 46. APAC Eye Drops for Glaucoma Revenue Market Share by Region (2017-2022)
Table 47. APAC Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 48. APAC Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)
Table 49. APAC Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 50. APAC Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)
Table 51. Europe Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)
Table 52. Europe Eye Drops for Glaucoma Sales Market Share by Country (2017-2022)
Table 53. Europe Eye Drops for Glaucoma Revenue by Country (2017-2022) & ($ Millions)
Table 54. Europe Eye Drops for Glaucoma Revenue Market Share by Country (2017-2022)
Table 55. Europe Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 56. Europe Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)
Table 57. Europe Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 58. Europe Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)
Table 59. Middle East & Africa Eye Drops for Glaucoma Sales by Country (2017-2022) & (K Units)
Table 60. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Country (2017-2022)
Table 61. Middle East & Africa Eye Drops for Glaucoma Revenue by Country (2017-2022) & ($ Millions)
Table 62. Middle East & Africa Eye Drops for Glaucoma Revenue Market Share by Country (2017-2022)
Table 63. Middle East & Africa Eye Drops for Glaucoma Sales by Type (2017-2022) & (K Units)
Table 64. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Type (2017-2022)
Table 65. Middle East & Africa Eye Drops for Glaucoma Sales by Application (2017-2022) & (K Units)
Table 66. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)
Table 67. Key Market Drivers & Growth Opportunities of Eye Drops for Glaucoma
Table 68. Key Market Challenges & Risks of Eye Drops for Glaucoma
Table 69. Key Industry Trends of Eye Drops for Glaucoma
Table 70. Eye Drops for Glaucoma Raw Material
Table 71. Key Suppliers of Raw Materials
Table 72. Eye Drops for Glaucoma Distributors List
Table 73. Eye Drops for Glaucoma Customer List
Table 74. Global Eye Drops for Glaucoma Sales Forecast by Region (2023-2028) & (K Units)
Table 75. Global Eye Drops for Glaucoma Sales Market Forecast by Region
Table 76. Global Eye Drops for Glaucoma Revenue Forecast by Region (2023-2028) & ($ millions)
Table 77. Global Eye Drops for Glaucoma Revenue Market Share Forecast by Region (2023-2028)
Table 78. Americas Eye Drops for Glaucoma Sales Forecast by Country (2023-2028) & (K Units)
Table 79. Americas Eye Drops for Glaucoma Revenue Forecast by Country (2023-2028) & ($ millions)
Table 80. APAC Eye Drops for Glaucoma Sales Forecast by Region (2023-2028) & (K Units)
Table 81. APAC Eye Drops for Glaucoma Revenue Forecast by Region (2023-2028) & ($ millions)
Table 82. Europe Eye Drops for Glaucoma Sales Forecast by Country (2023-2028) & (K Units)
Table 83. Europe Eye Drops for Glaucoma Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Middle East & Africa Eye Drops for Glaucoma Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Middle East & Africa Eye Drops for Glaucoma Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Global Eye Drops for Glaucoma Sales Forecast by Type (2023-2028) & (K Units)
Table 87. Global Eye Drops for Glaucoma Sales Market Share Forecast by Type (2023-2028)
Table 88. Global Eye Drops for Glaucoma Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 89. Global Eye Drops for Glaucoma Revenue Market Share Forecast by Type (2023-2028)
Table 90. Global Eye Drops for Glaucoma Sales Forecast by Application (2023-2028) & (K Units)
Table 91. Global Eye Drops for Glaucoma Sales Market Share Forecast by Application (2023-2028)
Table 92. Global Eye Drops for Glaucoma Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 93. Global Eye Drops for Glaucoma Revenue Market Share Forecast by Application (2023-2028)
Table 94. Thea Pharmaceuticals Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 95. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Product Offered
Table 96. Thea Pharmaceuticals Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 97. Thea Pharmaceuticals Ltd Main Business
Table 98. Thea Pharmaceuticals Ltd Latest Developments
Table 99. FDC International Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 100. FDC International Ltd Eye Drops for Glaucoma Product Offered
Table 101. FDC International Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 102. FDC International Ltd Main Business
Table 103. FDC International Ltd Latest Developments
Table 104. Martindale Pharma Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 105. Martindale Pharma Eye Drops for Glaucoma Product Offered
Table 106. Martindale Pharma Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 107. Martindale Pharma Main Business
Table 108. Martindale Pharma Latest Developments
Table 109. Zentiva Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 110. Zentiva Eye Drops for Glaucoma Product Offered
Table 111. Zentiva Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 112. Zentiva Main Business
Table 113. Zentiva Latest Developments
Table 114. Upjohn UK Limited Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 115. Upjohn UK Limited Eye Drops for Glaucoma Product Offered
Table 116. Upjohn UK Limited Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 117. Upjohn UK Limited Main Business
Table 118. Upjohn UK Limited Latest Developments
Table 119. Beacon Pharmaceuticals Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 120. Beacon Pharmaceuticals Eye Drops for Glaucoma Product Offered
Table 121. Beacon Pharmaceuticals Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 122. Beacon Pharmaceuticals Main Business
Table 123. Beacon Pharmaceuticals Latest Developments
Table 124. Novartis Pharmaceuticals UK Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 125. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Product Offered
Table 126. Novartis Pharmaceuticals UK Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 127. Novartis Pharmaceuticals UK Ltd Main Business
Table 128. Novartis Pharmaceuticals UK Ltd Latest Developments
Table 129. Mylan Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 130. Mylan Eye Drops for Glaucoma Product Offered
Table 131. Mylan Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 132. Mylan Main Business
Table 133. Mylan Latest Developments
Table 134. Accord Healthcare Limited Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 135. Accord Healthcare Limited Eye Drops for Glaucoma Product Offered
Table 136. Accord Healthcare Limited Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 137. Accord Healthcare Limited Main Business
Table 138. Accord Healthcare Limited Latest Developments
Table 139. Sandoz Limited Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 140. Sandoz Limited Eye Drops for Glaucoma Product Offered
Table 141. Sandoz Limited Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 142. Sandoz Limited Main Business
Table 143. Sandoz Limited Latest Developments
Table 144. Thornton & Ross Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 145. Thornton & Ross Ltd Eye Drops for Glaucoma Product Offered
Table 146. Thornton & Ross Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 147. Thornton & Ross Ltd Main Business
Table 148. Thornton & Ross Ltd Latest Developments
Table 149. Aspire Pharma Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 150. Aspire Pharma Ltd Eye Drops for Glaucoma Product Offered
Table 151. Aspire Pharma Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 152. Aspire Pharma Ltd Main Business
Table 153. Aspire Pharma Ltd Latest Developments
Table 154. AbbVie Ltd Basic Information, Eye Drops for Glaucoma Manufacturing Base, Sales Area and Its Competitors
Table 155. AbbVie Ltd Eye Drops for Glaucoma Product Offered
Table 156. AbbVie Ltd Eye Drops for Glaucoma Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)
Table 157. AbbVie Ltd Main Business
Table 158. AbbVie Ltd Latest Developments
List of Figures
Figure 1. Picture of Eye Drops for Glaucoma
Figure 2. Eye Drops for Glaucoma Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Eye Drops for Glaucoma Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Eye Drops for Glaucoma Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Eye Drops for Glaucoma Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Bimatoprost
Figure 10. Product Picture of Latanoprost
Figure 11. Product Picture of Tafluprost
Figure 12. Product Picture of Travoprost
Figure 13. Global Eye Drops for Glaucoma Sales Market Share by Type in 2021
Figure 14. Global Eye Drops for Glaucoma Revenue Market Share by Type (2017-2022)
Figure 15. Eye Drops for Glaucoma Consumed in Hospital
Figure 16. Global Eye Drops for Glaucoma Market: Hospital (2017-2022) & (K Units)
Figure 17. Eye Drops for Glaucoma Consumed in Ophthalmic Clinic
Figure 18. Global Eye Drops for Glaucoma Market: Ophthalmic Clinic (2017-2022) & (K Units)
Figure 19. Eye Drops for Glaucoma Consumed in Pharmacy
Figure 20. Global Eye Drops for Glaucoma Market: Pharmacy (2017-2022) & (K Units)
Figure 21. Eye Drops for Glaucoma Consumed in Others
Figure 22. Global Eye Drops for Glaucoma Market: Others (2017-2022) & (K Units)
Figure 23. Global Eye Drops for Glaucoma Sales Market Share by Application (2017-2022)
Figure 24. Global Eye Drops for Glaucoma Revenue Market Share by Application in 2021
Figure 25. Eye Drops for Glaucoma Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Eye Drops for Glaucoma Revenue Market Share by Company in 2021
Figure 27. Global Eye Drops for Glaucoma Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Eye Drops for Glaucoma Revenue Market Share by Geographic Region in 2021
Figure 29. Global Eye Drops for Glaucoma Sales Market Share by Region (2017-2022)
Figure 30. Global Eye Drops for Glaucoma Revenue Market Share by Country/Region in 2021
Figure 31. Americas Eye Drops for Glaucoma Sales 2017-2022 (K Units)
Figure 32. Americas Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)
Figure 33. APAC Eye Drops for Glaucoma Sales 2017-2022 (K Units)
Figure 34. APAC Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)
Figure 35. Europe Eye Drops for Glaucoma Sales 2017-2022 (K Units)
Figure 36. Europe Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Eye Drops for Glaucoma Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Eye Drops for Glaucoma Revenue 2017-2022 ($ Millions)
Figure 39. Americas Eye Drops for Glaucoma Sales Market Share by Country in 2021
Figure 40. Americas Eye Drops for Glaucoma Revenue Market Share by Country in 2021
Figure 41. United States Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Eye Drops for Glaucoma Sales Market Share by Region in 2021
Figure 46. APAC Eye Drops for Glaucoma Revenue Market Share by Regions in 2021
Figure 47. China Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Eye Drops for Glaucoma Sales Market Share by Country in 2021
Figure 54. Europe Eye Drops for Glaucoma Revenue Market Share by Country in 2021
Figure 55. Germany Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Eye Drops for Glaucoma Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Eye Drops for Glaucoma Revenue Market Share by Country in 2021
Figure 62. Egypt Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Eye Drops for Glaucoma Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Eye Drops for Glaucoma in 2021
Figure 68. Manufacturing Process Analysis of Eye Drops for Glaucoma
Figure 69. Industry Chain Structure of Eye Drops for Glaucoma
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...